文献速递急性肾损伤遗传性与小管间质肾病

免疫治疗肾毒性的人源化免疫系统小鼠模型病理发现

Pathological findings of immunotherapy-induced nephrotoxicity in a humanized immune system mouse model.
PubMed 文献 · Kidney Int · 2025-02-06

研究评估人源化免疫系统(HIS)荷瘤小鼠模型能否再现免疫检查点抑制剂(ICI)所致肾损伤。将人乳腺癌细胞植入非人源化(BRGS)与人源化(HIS-BRGS)小鼠,给予纳武利尤单抗或纳武利尤单抗联合伊匹木单抗四周。HIS-BRGS小鼠出现显著间质性肾炎和血管炎/动脉周围炎,联合治疗病变更广泛并伴T辅助细胞积聚,提示该模型可再现患者ICI肾损伤特征。

要点

  • HIS-BRGS荷瘤小鼠经ICI治疗可再现间质性肾炎和血管炎/动脉周围炎。
  • 纳武利尤单抗联合伊匹木单抗所致肾脏病理较纳武利尤单抗单药更广泛。
  • 联合治疗组病变区域可见T辅助细胞积聚。

核心结论

  • HIS-BRGS小鼠可有效再现患者ICI所致肾损伤特征,并可用于研究机制与预防策略。

研究设计与样本

  • 研究将人乳腺癌细胞植入非人源化BRGS小鼠与人源化HIS-BRGS小鼠。
  • 小鼠接受纳武利尤单抗(抗PD-1)或纳武利尤单抗联合伊匹木单抗(抗CTLA-4)治疗四周。
  • 研究对小鼠肾脏进行组织病理学分析。

主要发现

  • HIS-BRGS小鼠经ICI治疗后出现显著间质性肾炎和血管炎/动脉周围炎,与患者肾脏表型一致。
  • 联合治疗所致肾脏病理较纳武利尤单抗单药更广泛。
  • 联合治疗组病变区域可见T辅助细胞积聚。

临床怎么用

  • 该模型可用于研究ICI肾损伤机制及筛选限制免疫相关不良事件(irAE)的预防策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

While immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, they can elicit organ-related immune-related adverse events (irAEs) such as kidney injury. Here, our study evaluated the ability of a humanized immune system (HIS) tumor-bearing mouse model to investigate ICI-mediated kidney injury. Non-humanized (BRGS) and humanized (HIS-BRGS) mice were implanted with human breast cancer cells and treated with either nivolumab (anti-PD-1) or a combination of nivolumab and ipilimumab (anti-CTLA-4) for four weeks. Histopathological analysis revealed that HIS-BRGS mice treated with ICIs exhibited significant interstitial nephritis and vasculitis/periarteritis, consistent with kidney phenotypes observed in patients. Combination therapy resulted in more extensive kidney pathology than nivolumab alone and exhibited an accumulation of T helper cells in the affected areas. Importantly, our results suggest that HIS-BRGS mice can effectively recapitulate features of ICI-induced kidney injury observed in patients and can be used to study mechanisms and prevention strategies to limit irAEs.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Asby SC, Thompson LE, Goedken M, et al. Pathological findings of immunotherapy-induced nephrotoxicity in a humanized immune system mouse model. Kidney Int. 2025. PMID: 39922378. doi:10.1016/j.kint.2025.01.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。